Website “Influence” Shouldn’t Make Firms Responsible For Content – PhRMA
Executive Summary
FDA’s social media guidance on interactive promotional materials should require companies to submit only content that they have control over, PhRMA and BIO tell FDA; industry asks for clarification on a firm’s responsibility for user-generated content, such as comments on off-label use.